Disease regression was associated with improved recurrence-free survival and overall survival among certain patients with stage 1 and 2 cutaneous melanomas, according to a study.
Archive | Of Interest
Regression may predict good prognosis in stage 1 and 2 cutaneous melanomas
Posted in Melanoma News, Health Professionals, Of Interest
Study reveals significant role of ADAMTS1 protein in uveal melanoma
Scientists from the University of Granada and GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), in a study led by Juan Carlos Rodríguez-Manzaneque, have demonstrated the significant role of a protein called ADAMTS1 in uveal melanoma, one of the rarest and most aggressive cancers that exist, which develops in the eye.
Posted in Melanoma News, Health Professionals, Of Interest
The Yin and Yang of BRAF, MEK and CDK4-6 targeted therapy
A new paper from the McArthur & Sheppard Laboratory, by Emily Lelliott et. al.
Posted in Melanoma News, Health Professionals, Of Interest, Publications, Scientific Publications
Improvements in treatments for NSCLC, blood cancers, and melanoma continue to accelerate annual drop in overall cancer mortality rates
Overall cancer mortality rates in the United States continued to drop precipitously, falling by 2.4% from 2017-2018, according to the American Cancer Society’s latest Cancer Statistics report.
Posted in Melanoma News, Health Professionals, Of Interest
